How to Buy Ars Pharmaceuticals Stock

Ars Pharmaceuticals Inc

ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites.

Ars Pharmaceuticals stock last closed at $8.30, down 6.64% from the previous day, and has decreased 28.01% in one year. It has overperformed other stocks in the Biotechnology industry by 0.1 percentage points. Ars Pharmaceuticals stock is currently +24.62% from its 52-week low of $6.66, and -56.08% from its 52-week high of $18.90.

At the moment, there are 99.3M SPRY shares outstanding. The market value of SPRY is $824.17M. In the past 24 hours, 1.47M SPRY shares were traded.

How to Buy Ars Pharmaceuticals Stock

Wondering how to invest in Ars Pharmaceuticals stock? Here's how.

  1. Choose where to buy Ars Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you figure out where to buy Ars Pharmaceuticals stock.
  2. Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Fund your investment account: Pick your payment method and add your details.
  4. Research Ars Pharmaceuticals stock: The Ars Pharmaceuticals ticker symbol is SPRY. Is Ars Pharmaceuticals stock a good investment? Should you buy shares of SPRY? How do SPRY's underlying business fundamentals look? Do top analysts think Ars Pharmaceuticals is a good buy? Why has SPRY's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if SPRY is a good stock to buy).
  5. Make your SPRY purchase: Decide if you will purchase SPRY shares at the current market price or use a limit order to buy SPRY shares at a given price.
  6. Keep tabs on your investment in SPRY: Create a watchlist to important updates regarding your investment in Ars Pharmaceuticals shares.

Step 1: Choose where to buy Ars Pharmaceuticals stock

You need a brokerage account to access the NASDAQ market and buy SPRY stock.

A brokerage account enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our analysis, eToro is the best place to buy stocks. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to world financial markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
  • Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've selected your brokerage, it's time to fill out some personal info so you can invest in SPRY today.

How to Set Up a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal data to create a new trading account.
  1. Submit your application by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your investment account

Now that you have filled out your info on app for stock market, you need to deposit funds:

Watch the video below for more details depositing funds into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Ars Pharmaceuticals stock

Once you have decided on the best place to buy Ars Pharmaceuticals stock, it's crucial to evaluate their stock prior to buying, so you truly wrap your head around the risk and upside.

Overview of key SPRY info

SPRY Price
$8.30
1w %
-0.95%
1y %
-28.01%
5y %
-85.97%
P/E
-4.77x
P/B
7.21x
P/S
9.71x
PEG
N/A
Revenue
$84.28M
Earnings
-$171.30M
Fore. Rev. Growth
70.02%
Fore. Earn. Growth
N/A
Market Cap
$824.17M
Next Earnings
Mar 19, 2026
Next Dividend
N/A

SPRY Due Diligence Score

WallStreetZen was created to help everyday investors do better fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on SPRY's stock page.

Is SPRY stock overvalued?

Investors use many financial metrics, analyses, models, and charts to gauge SPRY's intrinsic value.

Using relative valuations metrics:

  • SPRY could be overvalued based on its P/B ratio of 7.21x, relative to Biotechnology industry P/B ratio of 4.65x

You can access more valuation analysis on SPRY's stock here.

SPRY Financial Health

Passed Financial Due Diligence Checks:

  • SPRY has cash burn of 171205000. It has enough cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than short-term liabilities on the SPRY balance sheet.
  • There are more short-term assets than long-term liabilities on the SPRY balance sheet.

Failed Financial Due Diligence Checks:

  • Total SPRY debt is higher than 5 years ago, relative to shareholder equity.
  • SPRY profit margin has gone down from 9% to -203.3% in the past year.
  • SPRY has $244.99M in cash and short term investments. This is not sufficient to cover its annual cash burn of $171.21M.
  • SPRY has a relatively high debt to equity ratio of 1.87.

You can dive deeper into what analysts are projecting on the Ars Pharmaceuticals stock forecast page.

SPRY Technical Indicators

SMA10
8.7
SMA20
8.94
SMA50
9.8
SMA100
9.67
SMA200
11.82
MACD
-0.34
MACD Signal
-0.33
MACD Histogram
0
RSI
37.36
Stochastic %K
31.98
Stochastic %D
28.5
StochRSI %K
74.18
StochRSI %D
59.61

SPRY Earnings

Last year, SPRY revenue was $84.28M. In the last four year, SPRY's revenue has gone up by 97.8% per year. This was faster than the Biotechnology industry average of 28.92%.

Learn more about SPRY's earnings and revenue performance here.

Latest Insiders Trades at SPRY

Over the past year, insiders at SPRY have sold more shares than they have bought.

Brian Dorsey, Chief Operating Officer of SPRY, was the latest SPRY insider to buy. They bought $13,969.92 worth of SPRY stock on Nov 13, 2025.

Dig into more about who owns SPRY shares here.

Does SPRY provide a stable income stream?

No, Ars Pharmaceuticals doesn't provide an income stream by paying out dividends.

Get opinions from other investors

One of the reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to learn what other community members have to say.

Step 5: Make your SPRY purchase

There are two primary order types:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are usually sufficient.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to be certain you're buying or selling at a specific dollar amount, place a limit order.

Hit the Open Trade button and eToro will execute the order.

If you require additional assistance buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Keep tabs on your investment in SPRY

Now that you own some SPRY shares, you'll want to stay up-to-date on your stock purchase.

Make a watchlist to track the most important metrics related to your SPRY stock.

SPRY Feed

How to Buy Stock in Ars Pharmaceuticals

To reiterate, here are the 6 steps to buy stock in Ars Pharmaceuticals:

  1. Choose where to buy Ars Pharmaceuticals stock
  2. Open your brokerage account
  3. Fund your investment account
  4. Research Ars Pharmaceuticals stock
  5. Make your SPRY purchase
  6. Keep tabs on your investment in SPRY

If you are looking for a brokerage account, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to track your new investment in Ars Pharmaceuticals, create a watchlist on WallStreetZen today.

NASDAQ: SPRY
$8.30-0.59 (-6.64%)
Updated Mar 18, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: SPRY
$8.30-0.59 (-6.64%)
Updated Mar 18, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Ars Pharmaceuticals share?

As of Mar 18, 2026, it costs $8.30 to buy one share of Ars Pharmaceuticals stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $4, you can buy 0.482 shares of SPRY.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

What is the best way to buy Ars Pharmaceuticals stock?

One way to place an order for Ars Pharmaceuticals stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.